Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-22

Clinical Trial Update: Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing intravenous haloperidol with ondansetron for established postoperative nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Ondansetron (ondansetron)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: COMPLETED